Design, synthesis, anticancer evaluation, and molecular dynamics-based computational investigation of novel pyrimidine-benzothiazole/phenyl hybrid-based VEGFR-2-targeted derivatives with antioxidant, DNA nicking, DNA interaction, and cytotoxicity studies
Bioorganic Chemistry · 2026
DOI: 10.1016/j.bioorg.2026.110422 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bioorganic Chemistry, 2026. Verfasst von Karan A Kamle und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, School of Science, Gujarat University, India. Hauptthemen laut MEDLINE: Vascular Endothelial Growth Factor Receptor-2, Benzothiazoles, Antineoplastic Agents, Pyrimidines. Die Arbeit nennt 45 Literaturangaben.
Abstract (Originalsprache)
A series of novel pyrimidine-based benzothiazole/phenyl hybrids was rationally designed and synthesized via molecular hybridization to develop promising anticancer agents. The compounds were evaluated against human lung carcinoma (A549) and breast adenocarcinoma (MCF-7) cell lines, while HEK-293 cells were used to assess selectivity toward normal cells. Among the derivatives, K12, K5, and K4 showed potent activity against A549 cells, with IC50 values of 6.18, 7.01, and 7.54 μM, respectively. K5 and K12 also showed significant activity against MCF-7 cells, with IC50 values of 8.33 and 9.30 μM, respectively. All compounds displayed minimal cytotoxicity toward HEK-293 cells, indicating favorable selectivity for cancer cells. UV-Vis DNA-binding studies suggested a probable intercalative binding mode, while DNA nicking assays demonstrated protection against oxidative DNA damage. K12 showed the strongest DNA-binding affinity and DNA-protective activity. Molecular docking against the VEGFR-2 kinase domain (PDB ID: 4ASD), followed by 501 ns MD simulations, revealed stable protein-ligand complexes, supported by RMSD, RMSF, DCCM, PCA, and free energy landscape analyses. MM/GBSA calculations indicated favorable binding free energies, dominated by van der Waals interactions. Overall, K12 emerged as the most promising lead compound, combining potent antiproliferative activity, high selectivity, efficient DNA-binding characteristics, and robust computational performance, highlighting its potential for further development as a novel anticancer agent.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, School of Science, Gujarat University, India.
- Department of Zoology, School of Science, Gujarat University, India.
- Department of Biotechnology, School of Basic Science, Sharda University, India.
- Department of Microbiology, School of Science, Gujarat University, India.
- Department of Botany, Bioinformatics, Climate Change and Impacts Management, School of Science, Gujarat University, India.
- Department of Chemistry, School of Science, Gujarat University, India. Electronic address: dvvasava@gujaratuniversity.ac.in.
Zitieren
APA
Kamle, K. A., Mevada, S. R., Hirani, R. H., Vanshiya, S., Gamit, N., Barad, R. K., Bhanugariya, N., Goswami, M., Thakar, M., Shindhav, G., Kumari, S., Priya, K., Vasava, H., Panchal, R., Dixit, N., Patel, S., & Vasava, D. V. (2026). Design, synthesis, anticancer evaluation, and molecular dynamics-based computational investigation of novel pyrimidine-benzothiazole/phenyl hybrid-based VEGFR-2-targeted derivatives with antioxidant, DNA nicking, DNA interaction, and cytotoxicity studies. Bioorganic Chemistry. https://doi.org/10.1016/j.bioorg.2026.110422
Vancouver
Kamle KA, Mevada SR, Hirani RH, Vanshiya S, Gamit N, Barad RK, et al. Design, synthesis, anticancer evaluation, and molecular dynamics-based computational investigation of novel pyrimidine-benzothiazole/phenyl hybrid-based VEGFR-2-targeted derivatives with antioxidant, DNA nicking, DNA interaction, and cytotoxicity studies. Bioorganic Chemistry. 2026. doi:10.1016/j.bioorg.2026.110422
BibTeX
@article{Kamle2026,
author = {Kamle, Karan A and Mevada, Shreyansh R and Hirani, Reena H and Vanshiya, Shailesh and Gamit, Nishith and Barad, Ravi K and Bhanugariya, Nigam and Goswami, Muskan and Thakar, Milan and Shindhav, Gaurang and Kumari, Shilpa and Priya, Kanu and Vasava, Himanshu and Panchal, Rakesh and Dixit, Nandan and Patel, Saumya and Vasava, Dilip V},
title = {Design, synthesis, anticancer evaluation, and molecular dynamics-based computational investigation of novel pyrimidine-benzothiazole/phenyl hybrid-based VEGFR-2-targeted derivatives with antioxidant, DNA nicking, DNA interaction, and cytotoxicity studies},
journal = {Bioorganic Chemistry},
year = {2026},
doi = {10.1016/j.bioorg.2026.110422}
}
EUVIMED